Colorectal cancer (CRC) is the third most common cancer worldwide and has become a progressively important public health problem that inevitably leads to an increase in morbidity and medical costs. Therefore, many countries have a screening program in place to lower the incidence of CRC. Subjects with a positive fecal immunochemical test (FIT) have a much higher likelihood of advanced neoplasms than the general population.However existing instruments have low portability.The purpose of this study is to test the performance of a Point-of-care testing instrument for fecal immunochemical test (FIT).
Age
Any age
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
People who use the new instrument for fecal immunochemical test(FIT)
People sign an "informed consent form"
You may not be if
People with history of surgery in any part of the large bowel;
People with symptoms including visible rectal bleeding, hematuria, hemorrhoid bleeds, severe and acute diarrhea and 7th type stool (Bristol feces score);
Clareo Health | Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test
